BROWN, LISLE/CUMMINGS, INC. SPRY — ARS PHARMACEUTICALS INC

Ownership history in BROWN, LISLE/CUMMINGS, INC.  ·  9 quarters on record

AI Ownership Summary

BROWN, LISLE/CUMMINGS, INC. reported ARS PHARMACEUTICALS INC (SPRY) in 9 quarterly 13F filings from 2024 Q3 through 2026 Q3. The latest visible filing shows SPRY at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SPRY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was BROWN, LISLE/CUMMINGS, INC.'s position in ARS PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

SPRY was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

SPRY stock page BROWN, LISLE/CUMMINGS, INC. fund profile BROWN, LISLE/CUMMINGS, INC. full holdings
How BROWN, LISLE/CUMMINGS, INC. held SPRY — position size vs. price
% of Fund (quarterly)    SPRY price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 UNCHANGED — — — 400 — 0% 0.00% $2K 2026-10-16 $4.02
2026 Q2 UNCHANGED — — — 400 — 0% 0.00% $3K 2026-09-02 $5.82
2026 Q1 UNCHANGED — — — 400 — 0% 0.00% $3K 2026-04-20 $8.18
2025 Q4 UNCHANGED — — — 400 — 0% 0.00% $5K 2026-01-23 $10.21
2025 Q3 UNCHANGED — — — 400 — 0% 0.00% $4K 2025-10-10 $11.32
2025 Q2 UNCHANGED — — — 400 — 0% 0.00% $7K 2025-07-16 $17.87
2025 Q1 UNCHANGED — — — 400 — 0% 0.00% $5K 2025-04-22 $15.00
2024 Q4 UNCHANGED — — — 400 — 0% 0.00% $4K 2025-01-27 $14.45
2024 Q3 INITIATED — — — 400 — — 0.00% $6K 2024-10-18 $15.99

🏢 Other funds also holding SPRY

As of 2026 Q3 — sorted by position size

Norman Fields, Gottscho Capital Management, LLC 3Y 7Y 0.08% Hennion & Walsh Asset Management, Inc. 3Y 0.03% Versant Capital Management, Inc 3Y 7Y 0.0% GAMMA Investing LLC 0.0% True Wealth Design, LLC 3Y 0.0% Essential Partners LLC 0.0% Farther Finance Advisors, LLC 3Y 0.0% TD Waterhouse Canada Inc. 0.0% IFP Advisors, Inc 3Y 7Y 0.0% GHP Investment Advisors, Inc. 3Y 7Y 0.0%

FAQ About BROWN, LISLE/CUMMINGS, INC. and SPRY

These are the practical questions this page is built to answer before you even open the full history table.

How long has BROWN, LISLE/CUMMINGS, INC. reported owning SPRY?

BROWN, LISLE/CUMMINGS, INC. reported SPRY across 9 quarterly 13F filings, from 2024 Q3 through 2026 Q3.

What was the largest reported SPRY position in BROWN, LISLE/CUMMINGS, INC.'s portfolio?

The largest reported portfolio weight for SPRY was 0.00% in 2025 Q2.

What is the latest reported SPRY position on this page?

The most recent filing on this page is 2026 Q3, when BROWN, LISLE/CUMMINGS, INC. reported 400 shares, equal to 0.00% of portfolio, with an estimated market value of $2K.

What does the chart on this SPRY ownership page compare?

The chart compares BROWN, LISLE/CUMMINGS, INC.'s quarterly SPRY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to BROWN, LISLE/CUMMINGS, INC. Holdings